Component

Guinea-pig fecal microbial community after fulvic formulations

Context-specific entity; species, compartment and exposure are stated on each claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Oral MLG formulations changed measured fecal microbiota composition and diversity in guinea pigs.

    Experimental context and source evidence
    evidence_access
    Primary full text
    experimental_model
    2026 MLG-50/MLG-A50 study; fossil extracts contain fulvic fractions plus mineral/polyphenol components, stock pH about 1.97/12.1. Preliminary groups n=8; oral 0.65 mg/kg twice daily for 21 days.
    limitations
    Co-components prevent assigning an effect to a single fulvic molecule. In-vitro activity is not established clinical benefit; preparation and dilution remain essential. Taxon abundance does not prove beneficial function, nutrient synthesis or improved human health; exploratory comparisons have multiplicity limitations.
    nutrient_topic
    Fulvic acid collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Fulvic acid (heterogeneous humic fraction)
    plain_language
    The preparations altered microbial-community measurements.
    primary_references
    Integrated safety and microbiota profiling of fulvic acid formulations across in vitro and in vivo models. · 2026 · https://pubmed.ncbi.nlm.nih.gov/41580488/ · DOI 10.1038/s41598-026-37331-2

    Fulvic acid: mixture identity, mineral chemistry, signaling and cross-nutrient mechanisms (2026-09-19) · lines 252–258

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · 2026 MLG-50/MLG-A50 study; fossil extracts contain fulvic fractions plus mineral/polyphenol components, stock pH about 1.97/12.1. Preliminary groups n=8; oral 0.65 mg/kg twice daily for 21 days. · source_derived_draft · unverified_draft

    ## fulvic-acid-guinea-pig-microbiota The preparations altered microbial-community measurements. Oral MLG formulations changed measured fecal microbiota composition and diversity in guinea pigs. Model: 2026 MLG-50/MLG-A50 study; fossil extracts contain fulvic fractions plus mineral/polyphenol components, stock pH about 1.97/12.1. Preliminary groups n=8; oral 0.65 mg/kg twice daily for 21 days. Limitations: Co-components prevent assigning an effect to a single fulvic molecule. In-vitro activity is not established clinical benefit; preparation and dilution remain essential. Taxon abundance does not prove beneficial function, nutrient synthesis or improved human health; exploratory comparisons have multiplicity limitations. Evidence access: Primary full text Integrated safety and microbiota profiling of fulvic acid formulations across in vitro and in vivo models. · 2026 · https://pubmed.ncbi.nlm.nih.gov/41580488/ · DOI 10.1038/s41598-026-37331-2
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards